s6y
Company name or ticker
Search
AN2 Therapeutics, Inc.
4
Readnour Robin Shane: Statement of changes in beneficial ownership of securities
Filed
Tuesday, September 8, 2026
Period
Sep 3, 2026
Accession number
0001193125-26-385511
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header